Literature DB >> 25060756

β-blockers for secondary prevention in stable coronary artery disease: can observational studies provide valid answers?

James S Floyd1.   

Abstract

Entities:  

Keywords:  CORONARY ARTERY DISEASE; MYOCARDIAL ISCHAEMIA AND INFARCTION (IHD)

Mesh：

Substances：

Year:  2014        PMID： 25060756      PMCID： PMC4230439          DOI： 10.1136/heartjnl-2014-306263

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  13 in total

1.  Are beta-blockers effective in elderly patients who undergo coronary revascularization after acute myocardial infarction?

Authors:  J Chen; M J Radford; Y Wang; T A Marciniak; H M Krumholz
Journal:  Arch Intern Med       Date:  2000-04-10

2.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.

Authors:  Clyde W Yancy; Mariell Jessup; Biykem Bozkurt; Javed Butler; Donald E Casey; Mark H Drazner; Gregg C Fonarow; Stephen A Geraci; Tamara Horwich; James L Januzzi; Maryl R Johnson; Edward K Kasper; Wayne C Levy; Frederick A Masoudi; Patrick E McBride; John J V McMurray; Judith E Mitchell; Pamela N Peterson; Barbara Riegel; Flora Sam; Lynne W Stevenson; W H Wilson Tang; Emily J Tsai; Bruce L Wilkoff
Journal:  Circulation       Date:  2013-06-05       Impact factor: 29.690

3.  Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction.

Authors:  S S Gottlieb; R J McCarter; R A Vogel
Journal:  N Engl J Med       Date:  1998-08-20       Impact factor: 91.245

4.  Prognostic impact of ß-blocker use in patients with stable coronary artery disease.

Authors:  Christophe Bauters; Gilles Lemesle; Thibaud Meurice; Olivier Tricot; Pascal de Groote; Nicolas Lamblin
Journal:  Heart       Date:  2014-06-19       Impact factor: 5.994

5.  Beta blockade during and after myocardial infarction: an overview of the randomized trials.

Authors:  S Yusuf; R Peto; J Lewis; R Collins; P Sleight
Journal:  Prog Cardiovasc Dis       Date:  1985 Mar-Apr       Impact factor: 8.194

6.  Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial.

Authors:  Z M Chen; H C Pan; Y P Chen; R Peto; R Collins; L X Jiang; J X Xie; L S Liu
Journal:  Lancet       Date:  2005-11-05       Impact factor: 79.321

7.  Use of a marginal structural model to determine the effect of aspirin on cardiovascular mortality in the Physicians' Health Study.

Authors:  Nancy R Cook; Stephen R Cole; Charles H Hennekens
Journal:  Am J Epidemiol       Date:  2002-06-01       Impact factor: 4.897

8.  Population trends in the incidence and outcomes of acute myocardial infarction.

Authors:  Robert W Yeh; Stephen Sidney; Malini Chandra; Michael Sorel; Joseph V Selby; Alan S Go
Journal:  N Engl J Med       Date:  2010-06-10       Impact factor: 91.245

9.  β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease.

Authors:  Sripal Bangalore; Gabriel Steg; Prakash Deedwania; Kevin Crowley; Kim A Eagle; Shinya Goto; E Magnus Ohman; Christopher P Cannon; Sidney C Smith; Uwe Zeymer; Elaine B Hoffman; Franz H Messerli; Deepak L Bhatt
Journal:  JAMA       Date:  2012-10-03       Impact factor: 56.272

10.  Evaluating medication effects outside of clinical trials: new-user designs.

Authors:  Wayne A Ray
Journal:  Am J Epidemiol       Date:  2003-11-01       Impact factor: 4.897
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.